Network News
Dr. Tanja Eichkorn, a scientist at Heidelberg University and physician at the Department of Radiation Oncology and Radiotherapy at Heidelberg University Hospital, has been awarded the Anita and Friedrich Reutner Prize of the Heidelberg Medical Faculty for her research into tissue damage in the brain following high-precision radiation with protons. More Information in German below. […]
read more
Promega develops new enzyme to significantly reduce stutter artifacts in forensic DNA analysis
Further Information in German below. Promega entwickelt neues Enzym zur signifikanten Reduktion von Stutter-Artefakten in der forensischen DNA-Analyse Madison, WI USA. (30. September 2024) Forschende der Promega Corporation haben ein neues Enzym entwickelt, das störende Stutter-Artefakte in der forensischen DNA-Analyse nahezu vollständig eliminiert. Dieses Enzym erleichtert erheblich die Dekonvolution von Mischspuren und ermöglicht Forensikerinnen und Forensikern, […]
read more
Startup immuneAdvice wins Young Scientists Pitch Competition
Success for the NMI spin-off immuneAdvice: the startup took first place in the Young Scientists Pitch Competition at the bioRN Annual Conference on Wednesday, October 9, 2024. Dr. Björn Tränkle, one of the founders, presented the business idea. The vision of immuneAdvice is the early response monitoring and control of immunotherapies with the so-called ICE-T […]
read more
What we can learn from hungry yeast cells
Scientists at EMBL Heidelberg and University of Virginia School of Medicine have discovered a curious way in which cells adapt to starvation – a mechanism with potential cancer implications Summary What can stressed yeast teach us about fundamental processes in the cell? A lot, according to EMBL Heidelberg’s Mattei Team. The team studies, among other topics, […]
read more
Stronger together: miniature robots in convoy for endoscopic surgery
Miniature robots on the millimeter scale often lack the strength to transport instruments for endoscopic microsurgery through the body. Scientists at the German Cancer Research Center (DKFZ) are now combining several millimeter-sized TrainBots into one unit and equipping them with improved “feet”. For the first time, the DKFZ team was able to perform an electric […]
read more
Critical Pathway for rare brain tumor discovered
Choroid plexus tumors mainly affect toddlers under one year of age. Scientists at the German Cancer Research Center (DKFZ) have now been able to show that a permanently activated important signaling pathway of intracellular communication is responsible for the development of these rare brain tumors. Tumors of the choroid plexus develop as a result of […]
read more
Language model “UroBot“ surpasses the accuracy of experienced urologists
Scientists at the German Cancer Research Center (DKFZ), together with doctors from the Urological Clinic of the Mannheim University Hospital, have developed and successfully tested a chatbot based on artificial intelligence. “UroBot” was able to answer questions from the urology specialist examination with a high degree of accuracy, surpassing both other language models and the […]
read more
New Member: Welcome in our cluster to iQMedix GmbH
iQMedix aims to improve the lives of cancer patients by providing personalized treatments based on molecular analysis. Using liquid biopsies to determine gene expression profiles from circulating tumor cells, iQMedix enables doctors to tailor therapies to each patient’s unique cancer. Their approach offers precise insights to determine effective treatments. Their vision is to make cancer […]
read more
New Member: Welcome in our cluster to !LEVA Sciences GmbH
!LEVA specializes in guiding pharmaceutical companies through the complexities of development, from company foundation to early clinical studies. Over the past 25 years, the !LEVA management team has co-founded and successfully managed nearly a dozen companies, mainly in the pharmaceutical sector, while supporting numerous biotech companies in corporate and product development. !LEVA Sciences was founded […]
read more
